AlphaFold predicted structure
MPDU1 · O75352

Mean pLDDT
88.8/ 100
Confident
247 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)25%
- Low(50–70)2%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mannose-P-dolichol utilization defect 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
MPDU1-congenital disorder of glycosylation
ALG13-CDG
PGM1-congenital disorder of glycosylation
RFT1-congenital disorder of glycosylation
developmental and epileptic encephalopathy, 36
congenital disorder of glycosylation type I
congenital disorder of glycosylation
SRD5A3-congenital disorder of glycosylation
hereditary disease
ichthyosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mannose-P-dolichol utilization defect 1 protein
Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors
MPDU1 · O75352

Mean pLDDT
88.8/ 100
Confident
247 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0